Antibiotics for Back Pain: Does a New Study Doom a Highly Publicized Treatment “Breakthrough”? Less The Back Letter. 35(2):13-21, February 2020. Favorites PDF Get Content & Permissions Buy
An Award for The BackLetter Less The Back Letter. 35(2):13-22, February 2020. Favorites PDF Get Content & Permissions Buy
Decline in Opioid Prescriptions for Low Back Pain Less The Back Letter. 35(2):14, February 2020. Favorites PDF Get Content & Permissions Buy
Spinal Medicine Warped by a Succession of False Narratives? Less The Back Letter. 35(2):15, February 2020. Favorites PDF Get Content & Permissions Buy
Fear of Pain Driving Overtreatment Less The Back Letter. 35(2):15, February 2020. Favorites PDF Get Content & Permissions Buy
Lancet Editor Takes Aim at a Dominant Form of Medical Evidence: Systematic Reviews Less The Back Letter. 35(2):16, February 2020. Favorites PDF Get Content & Permissions Buy
End Commercial Support for Back Pain Research? Less The Back Letter. 35(2):17, February 2020. Favorites PDF Get Content & Permissions Buy
Spinal Imaging a Persistent Problem in Emergency Care Less The Back Letter. 35(2):17, February 2020. Favorites PDF Get Content & Permissions Buy
Evidence in Multiple Areas Trending Against Antibiotics for Back Pain in the Presence of Modic Changes Less The Back Letter. 35(2):21, February 2020. Favorites PDF Get Content & Permissions Buy
Violence, Chronic Pain, and Fatigue Less The Back Letter. 35(2):22, February 2020. Favorites PDF Get Content & Permissions Buy
THE BACK PAGE Less The Back Letter. 35(2):24, February 2020. Favorites PDF Get Content & Permissions Buy
BackPage Online, February 2020 Less The Back Letter. 35(2):e1, February 2020. Favorites PDF Get Content & Permissions Free
MEETING CALENDAR Less The Back Letter. 35(2):23, February 2020. Favorites PDF Get Content & Permissions Buy
